Structure and Context of acinetobacter transposons carrying the oxa23 carbapenemase gene

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 5, 2016, Pages 1135-1147

  Nigro, Steven J ^a   Hall, Ruth M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; BETA LACTAMASE; BETA-LACTAMASE OXA-23; TRANSPOSON;

ABAR4 GENE; ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER RADIORESISTENS; ARTICLE; BACTERIAL GENE; CHINA; ENTEROBACTERIACEAE; GENE EXPRESSION; GENETIC VARIABILITY; NONHUMAN; OXA23 GENE; PROMOTER REGION; TN2006 GENE; TN2007 GENE; TN2008 GENE; TN2008B GENE; TN2009 GENE; TRANSPOSON; ENZYMOLOGY; GENETICS; GLOBAL HEALTH; HUMAN; MOLECULAR EVOLUTION;

ACINETOBACTER; BETA-LACTAMASES; DNA TRANSPOSABLE ELEMENTS; EVOLUTION, MOLECULAR; GLOBAL HEALTH; HUMANS;

EID: 84965082207     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv440     Document Type: Article

References (68)

1. Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 2011; 63: 1061-7.
2. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
3. Brown S, Young HK, Amyes SG. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005; 11: 15-23.
4. Figueiredo S, Poirel L, Croize J, et al. In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural blaOXA-66 oxacillinase gene. Antimicrob Agents Chemother 2009; 53: 2657-9.
5. Lee YT, Turton JF, Chen TL, et al. First identification of blaOXA-51-like in nonbaumannii Acinetobacter spp. J Chemother 2009; 21: 514-20.
6. Turton JF,Woodford N, Glover J, et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44: 2974-6.
7. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D b-lactamases. Antimicrob Agents Chemother 2010; 54: 24-38.
8. Higgins PG, Poirel L, Lehmann M, et al. OXA-143, a novel carbapenemhydrolyzing class D b-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53: 5035-8.
9. Higgins PG, Perez-Llarena FJ, Zander E, et al. OXA-235, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2013; 57: 2121-6.
10. Evans BA, Amyes SG. OXA b-lactamases. Clin Microbiol Rev 2014; 27: 241-63.
11. Mugnier PD, Poirel L, Naas T, et al. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010; 16: 35-40.
12. Corvec S, Poirel L, Naas T, et al. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 1530-3.
13. Adams-Haduch JM, Paterson DL, Sidjabat HE, et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 2008; 52: 3837-43.
14. Nigro S, Hall RM. Distribution of the blaOXA-23-containing transposons Tn2006 and Tn2008 in Australian carbapenem-resistant Acinetobacter baumannii isolates. J Antimicrob Chemother 2015; 70: 2409-11.
15. Wang X, Zong Z, Lu X. Tn2008 is a major vehicle carrying blaOXA-23 in Acinetobacter baumannii from China. Diagn Microbiol Infect Dis 2011; 69: 218-22.
16. Zhou H, Zhang T, Yu D, et al. Genomic analysis of the multidrugresistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother 2011; 55: 4506-12.
17. Mugnier PD, Poirel L, Nordmann P. Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J Bacteriol 2009; 191: 2414-8.
18. Paton R, Miles RS, Hood J, et al. ARI 1: b-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993; 2: 81-7.
19. Donald HM, ScaifeW, Amyes SG, et al. Sequence analysis of ARI-1, a novel OXA b-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother 2000; 44: 196-9.
20. Scaife W, Young HK, Paton RH, et al. Transferable imipenem-resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother 1995; 36: 585-6.
21. Segal H, Jacobson RK, Garny S, et al. Extended210 promoter in ISAba-1 upstream of blaOXA-23 from Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 3040-1.
22. Hamidian M, Hall RM. ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistance. J Antimicrob Chemother 2013; 68: 2682-3.
23. Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006; 57: 373-83.
24. Heritier C, Poirel L, Lambert Tet al. Contribution of acquired carbapenemhydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 3198-202.
25. Poirel L, Figueiredo S, Cattoir V, et al. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008; 52: 1252-6.
26. Bonnin RA, Poirel L, Licker M, et al. Genetic diversity of carbapenemhydrolysing b-lactamases in Acinetobacter baumannii from Romanian hospitals. Clin Microbiol Infect 2011; 17: 1524-8.
27. Gheorghe I, Novais A, Grosso F, et al. Snapshot on carbapenemaseproducing Pseudomonas aeruginosa and Acinetobacter baumannii in Bucharest hospitals reveals unusual clones and novel genetic surroundings for blaOXA-23. J Antimicrob Chemother 2015; 70: 1016-20.
28. Izdebski R, Fiett J, Hryniewicz W, et al. Molecular analysis of Acinetobacter baumannii isolates from invasive infections in 2009 in Poland. J Clin Microbiol 2012; 50: 3813-5.
29. Ku WW, Kung CH, Lee CH, et al. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan. J Microbiol Immunol Infect 2015; 48: 57-64.
30. Lee HY, Huang CW, Chen CL, et al. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients. J Microbiol Immunol Infect 2015; doi:10.1016/ j.jmii.2015.03.003.
31. Lee MH, Chen TL, Lee YT, et al. Dissemination of multidrug-resistant Acinetobacter baumannii carrying blaOXA-23 from hospitals in central Taiwan. J Microbiol Immunol Infect 2013; 46: 419-24.
32. Liu LL, Ji SJ, Ruan Z, et al. Dissemination of blaOXA-23 in Acinetobacter spp. in China: main roles of conjugative plasmid pAZJ221 and transposon Tn2009. Antimicrob Agents Chemother 2015; 59: 1998-2005.
33. Manageiro V, Jones-Dias D, Ferreira E, et al. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int J Antimicrob Agents 2012; 40: 398-403.
34. Nigro SJ, Holt KE, Pickard D, et al. Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid. J Antimicrob Chemother 2015; 70: 1259-61.
35. Wang D, Yan D, HouWet al. Characterization of blaOXA-23 gene regions in isolates of Acinetobacter baumannii. J Microbiol Immunol Infect 2015; 48: 284-90.
36. Zhou Z, Du X, Wang L, et al. Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China. Antimicrob Agents Chemother 2011; 55: 5347-9.
37. Wright MS, Haft DH, Harkins DM, et al. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. MBio 2014; 5: e00963-13.
38. Adams MD, Goglin K, Molyneaux N, et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008; 190: 8053-64.
39. Espinal P, Macia MD, Roca I, et al. First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. Antimicrob Agents Chemother 2013; 57: 589-91.
40. Grosso F, Carvalho KR, Quinteira S, et al. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother 2011; 66: 62-5.
41. Grosso F, Quinteira S, Peixe L. Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal. Clin Microbiol Infect 2011; 17: 1275-9.
42. Hamidian M, Hall RM. AbaR4 replaces AbaR3 in a carbapenemresistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital. J Antimicrob Chemother 2011; 66: 2484-91.
43. Hamidian M, Kenyon JJ, Holt KE, et al. A conjugative plasmid carrying the carbapenem resistance gene blaOXA-23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate. J Antimicrob Chemother 2014; 69: 2625-8.
44. Kim DH, Park YK, Ko KS. Variations of AbaR4-type resistance islands in Acinetobacter baumannii isolates from South Korea. Antimicrob Agents Chemother 2012; 56: 4544-7.
45. Lee HY, Chang RC, Su LH, et al. Wide spread of Tn2006 in an AbaR4- type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int J Antimicrob Agents 2012; 40: 163-7.
46. Minandri F, D'Arezzo S, Antunes LC, et al. Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol 2012; 50: 590-7.
47. Mosqueda N, Espinal P, Cosgaya C, et al. Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of Acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother 2013; 57: 5155-7.
48. Mugnier P, Poirel L, Pitout M, et al. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin Microbiol Infect 2008; 14: 879-82.
49. Nigro SJ, Hall RM. Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate. J Antimicrob Chemother 2012; 67: 1342-6.
50. Nigro SJ, Post V, Hall RM. Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. J Antimicrob Chemother 2011; 66: 1504-9.
51. Saule M, Samuelsen O, Dumpis U, et al. Dissemination of a carbapenemresistant Acinetobacter baumannii strain belonging to international clone II/ sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia. Antimicrob Agents Chemother 2013; 57: 1069-72.
52. Seputiene V, Povilonis J, Suziedeliene E. Novel variants of AbaR resistance islands with a common backbone in Acinetobacter baumannii isolates of European clone II. Antimicrob Agents Chemother 2012; 56: 1969-73.
53. Tada T, Miyoshi-Akiyama T, Shimada K, et al. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 2014; 58: 2916-20.
54. Turton JF, Baddal B, Perry C. Use of the accessory genome for characterization and typing of Acinetobacter baumannii. J Clin Microbiol 2011; 49: 1260-6.
55. Zarrilli R, Di Popolo A, BagattiniMet al. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J Hosp Infect 2012; 82: 260-5.
56. Nigro SJ, Farrugia DN, Paulsen IT, et al. A novel family of genomic resistance islands, AbGRI2, contributing to aminoglycoside resistance in Acinetobacter baumannii isolates belonging to global clone 2. J Antimicrob Chemother 2013; 68: 554-7.
57. Bertini A, Poirel L, Mugnier PD, et al. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54: 4168-77.
58. Huang H, Yang ZL, Wu XM, et al. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance. J Antimicrob Chemother 2012; 67: 2825-32.
59. Zhu L, Yan Z, Zhang Z, et al. Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements. PLoS One 2013; 8: e66584.
60. Bogaerts P, Cuzon G, Naas Tet al. Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother 2008; 52: 4205-6.
61. Guerrero-Lozano I, Fernandez-Cuenca F, Galan-Sanchez F, et al. Description of the OXA-23 b-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain. Microb Drug Resist 2015; 21: 215-7.
62. Kim DH, Ko KS. AbaR-type genomic islands in non-Acinetobacter baumannii isolates from Korea. Antimicrob Agents Chemother 2015; 59: 5824-6.
63. Weber BS, Ly PM, Irwin JN, et al. A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii. Proc Natl Acad Sci USA 2015; 112: 9442-7.
64. Towner KJ, Evans B, Villa L, et al. Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D b-lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 2154-9.
65. Poirel L, Bercot B, Millemann Y, et al. Carbapenemase-producing Acinetobacter spp. in cattle, France. Emerg Infect Dis 2012; 18: 523-5.
66. Smet A, Boyen F, Pasmans F, et al. OXA-23-producing Acinetobacter species from horses: a public health hazard? J Antimicrob Chemother 2012; 67: 3009-10.
67. Pomba C, Endimiani A, Rossano A, et al. First report of OXA-23-mediated carbapenem resistance in sequence type 2multidrug-resistant Acinetobacter baumannii associated with urinary tract infection in a cat. Antimicrob Agents Chemother 2014; 58: 1267-8.
68. La MV, Jureen R, Lin RT, et al. Unusual detection of an Acinetobacter class D carbapenemase gene, blaOXA-23, in a clinical Escherichia coli isolate. J Clin Microbiol 2014; 52: 3822-3.